Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

Familial cancer - 1 Jul 2018

Kearton Stephanie, Wills Karen, Bunting Michael, Blomfield Penny, James Paul A, Burke Jo

Abstract excerpt

Women carrying germline mutations in BRCA1 or BRCA2 have significantly increased lifetime risks of breast and tubo-ovarian cancer. To manage the breast cancer risk women may elect to have breast screening by MRI/mammogram from age 30, to take risk-reducing medication, or to have a prophylactic bilateral mastectomy. To manage the tubo-ovarian cancer risk, the only effective strategy is to have a bilateral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, BRCA1
Share to Genes, BRCA2
Share to Hereditary Breast and Ovarian Cancer Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Acceptance of Health Care

Share to Prophylactic Mastectomy

Share to Salpingo-oophorectomy

Share to Surveys and Questionnaires

Share to Tasmania

Source

Identifiers

PMID: 29039136
DOI: 10.1007/s10689-017-0047-1

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.PMID 29039136Read ↗

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read ↗

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Semantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.Semantic proximity Read ↗

Discussion of "Risk management decisions in women with BRCA1 and BRCA2 mutations".Semantic proximity Read ↗

Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk-reducing surgeries in BRCA mutation carriers.Semantic proximity Read ↗

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.